Thermo Fisher Scientific Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel

Thermo Fisher Scientific has launched the Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable product that contains 22 real-time PCR assays for the identification of SARS-CoV-2 mutations. The panel is designed to be highly scalable, allowing hundreds of samples to be analyzed in parallel. It provides results in about one hour and uses TaqMan SNP genotyping assay technology.